Prostaglandin analogue protects pancreatic B-cells against cyclosporin A toxicity

M. Löhr, M. K. Müller, H. Goebell, G. Klöppel

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Cyclosporin A toxicity on pancreatic B-cells and its prevention by rioprostil, a prostaglandin E1 analogue, were studied in the model of the isolated perfused pancreas of rats treated with both compounds for 8 days. At toxic doses of cyclosporin (10 and 20 mg/kg b.wt), the B-cells showed severe hydropic degeneration of the endoplasmatic reticulum and slight degranulation of the B-cells. Accordingly, the insulin secretion was markedly impaired. Administration of rioprostil ameliorated the insulin secretion significantly, but not the ultrastructural changes. At therapeutic levels of cyclosporin (5 mg/kg b.wt), the hydropic degeneration and the drop in insulin secretion were completely prevented by rioprostil. This observation might have therapeutic implications in the treatment of patients, in particular those undergoing pancreatic transplantation.

Original languageEnglish
Pages (from-to)352-355
Number of pages4
Issue number4
StatePublished - Apr 1989
Externally publishedYes


  • Cytoprotection
  • cyclosporin
  • electron microscopy
  • endocrine pancreas
  • insulin-secretion
  • prostaglandin analogue
  • rioprostil


Dive into the research topics of 'Prostaglandin analogue protects pancreatic B-cells against cyclosporin A toxicity'. Together they form a unique fingerprint.

Cite this